The partnership aims to create a non-viral system to expedite engineered cell therapy delivery by addressing bottlenecks.

This research investigates how to optimize mRNA transfection in human T-cells utilizing the jetMESSENGER ® transfection reagent. By using advanced bioanalytical instruments like the Incucyte ® ...

Kytopen Corp., a leader in providing continuous flow cellular engineering technologies, announced today its collaboration with BlueWhale Bio, Inc., a company dedicated to accelerating the growth and ...

This review article highlights the transformative potential of in vivo CAR T cell therapy in addressing the limitations of ...

This application note explores how advanced SFM formulations can dramatically improve CRISPR-modified CAR-T cell production ...

In the rapidly evolving field of lipid nanoparticle (LNP) research, the integration of advanced technologies is crucial for ...

This review article focuses on the transformative potential of in vivo CAR T cell treatment in overcoming the constraints of ...